This effect also in line with previous work that showed treatment with omaveloxolone significantly decreased MMP-9 levels in rat model of COPD and this finding correlated with activation of Nrf2 signaling pathway and inhibition of NFkB according to the tested parameters [67], [68]. The gene discussed is NFKB1; the disease is chronic obstructive pulmonary disease.